EHRA Premium Access

AF in HFrEF, HFmrEF and HFpEF: does it make any difference?

Presentation

About the speaker

Professor Rudolf De Boer

University Medical Center Groningen, Groningen (Netherlands (The))
41 presentations
0 follower

4 more presentations in this session

SGLT2 blockers in AF: the best AAD ever?

Speaker: Professor F. Ruschitzka (Zurich, CH)

Thumbnail

Insights from the Castle AF: why was it positive?

Speaker: Professor N. Marrouche (New Orleans, US)

Thumbnail

The future of AF ablation in heart failure.

Speaker: Professor D. Gupta (Liverpool, GB)

Thumbnail

Atrial Fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference? - discussion.

Thumbnail

Access the full session

Atrial fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference?

Speakers: Professor R. De Boer, Professor F. Ruschitzka, Professor N. Marrouche, Professor D. Gupta
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

Open Access

Hot topics in atrial fibrillation.

5 April 2022

EHRA Premium Access

EHRA expect consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.

3 April 2022

EHRA Premium Access

EHRA position paper on leadless pacing and extravascular defibrillators.

3 April 2022

This platform is supported by

logo Novo Nordisk